Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    18784101 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
Condition: Head and Neck Cancer
Interventions: Drug: Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU);   Drug: Platinum (Cisplatin or Carboplatin) + 5-FU
2 Active, not recruiting Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer
Condition: Esophageal Squamous Cell Cancer
Interventions: Drug: Cisplatin, 5-FU;   Drug: Panitumumab
3 Withdrawn Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
Condition: Squamous Cell Carcinoma of the Penis
Interventions: Drug: Cetuximab;   Drug: TIP

Study has passed its completion date and status has not been verified in more than two years.